Cargando…

Thromboprophylaxis for medical inpatients with coronavirus disease 2019

Detalles Bibliográficos
Autores principales:	Dalager-Pedersen, M., Bodilsen, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245295/ https://www.ncbi.nlm.nih.gov/pubmed/32454190 http://dx.doi.org/10.1016/j.cmi.2020.05.021

Ejemplares similares

Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond
por: Dalager-Pedersen, Michael
Publicado: (2022)

Overuse and underuse of thromboprophylaxis in medical inpatients
por: Kocher, Barbara, et al.
Publicado: (2023)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?
por: Rezende, Suely M., et al.
Publicado: (2023)

Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
por: Di Renzo, Gian Carlo, et al.
Publicado: (2020)

Pulmonary thromboembolism in coronavirus disease 2019 patients undergoing thromboprophylaxis
por: Schiaffino, Simone, et al.
Publicado: (2021)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Therapeutic potential of inhalable medications to combat coronavirus disease-2019
por: Parvathaneni, Vineela, et al.
Publicado: (2020)

Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort
por: Blondon, Marc, et al.
Publicado: (2020)

Proposal for Coronavirus Disease 2019 Management
por: Downs, John B., et al.
Publicado: (2020)

Which are the best coronavirus disease 2019 vaccines?
por: Omrani, Ali S., et al.
Publicado: (2021)

Clinical Distancing and Mitigation of Coronavirus Disease 2019
por: Scott, Benjamin K., et al.
Publicado: (2020)

Commentary: The molecular pandemonium of coronavirus disease 2019
por: Balsam, Leora B., et al.
Publicado: (2021)

Is It Time for Coronavirus Disease-2019 Vaccine Mandates?
por: Bernstein, Henry H., et al.
Publicado: (2022)

Adherence to Venous Thromboprophylaxis Guidelines for Medical and Surgical Inpatients of Teaching Hospitals, Shiraz-Iran
por: Manoucheri, Reza, et al.
Publicado: (2015)

Time to antibiotic therapy and outcome in bacterial meningitis: a Danish population-based cohort study
por: Bodilsen, Jacob, et al.
Publicado: (2016)

Cancer patients and coronavirus disease 2019: evidence in context
por: Barba, Maddalena, et al.
Publicado: (2020)

Does Pulmonary Aspergillosis Complicate Coronavirus Disease 2019?
por: Beer, Karlyn D., et al.
Publicado: (2020)

Convalescent Plasma for Coronavirus Disease 2019: Dose is the Key
por: Yu, Jiangquan, et al.
Publicado: (2021)

Preparedness for further boosting coronavirus disease 2019 vaccines
por: Lim, So Yun, et al.
Publicado: (2022)

Coronavirus Disease 2019 and Vaccination of Children and Adolescents: Prospects and Challenges
por: Zimet, Gregory D., et al.
Publicado: (2021)

Implications of current and future approaches to coronavirus disease 2019 testing
por: Smith, Rasheid, et al.
Publicado: (2020)

The role of a Coronavirus disease 2019 pharmacist: an Australian perspective
por: Nguy, Jenny, et al.
Publicado: (2020)

Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina
por: Languasco, Agustín, et al.
Publicado: (2011)

Commentary: Coronavirus disease 2019 (COVID-19): The long (term) and short (term) of it
por: Wisniewski, Alex M., et al.
Publicado: (2021)

Dangers of scientific bias against herbal drugs for coronavirus disease 2019
por: Fields, Jonathan M.
Publicado: (2020)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Commentary: Training in the time of coronavirus disease 2019 (COVID-19)
por: Tibayan, Frederick A.
Publicado: (2021)

Commentary: Obesity in the time of coronavirus disease 2019 (COVID-19)
por: Shah, Ashish S.
Publicado: (2021)

Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope?
por: Lau, Harry Cheuk-Hay, et al.
Publicado: (2022)

Arrhythmias in the Age of Coronavirus Disease 2019
por: Niazi, Imran, et al.
Publicado: (2021)

Clinical Pharmacists: An Invaluable Part of the Coronavirus Disease 2019 Frontline Response
por: Ferguson, Nadia C., et al.
Publicado: (2020)

Clinical trials for coronavirus disease 2019: What is being evaluated and what is not
por: Arabi, Yaseen M., et al.
Publicado: (2020)

Pharmacists as important prescribers of coronavirus disease 2019 (COVID-19) antivirals
por: Mahoney, Monica V., et al.
Publicado: (2022)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients
por: Cheng, Biao
Publicado: (2020)

From the trenches: inpatient management of coronavirus disease 2019 in pregnancy
por: Vega, Marisa, et al.
Publicado: (2020)

Commentary: Cardiac care during the coronavirus disease 2019 pandemic: Competing constraints
por: Reardon, Michael J.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stqbbabooiosfallp6r7m360s5